Fig. 1From: A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarkerWestern blot assays were performed on serum sampled from patients prior to treatment, and at one-week post treatment. UT = untreated, T = treated. White space delineates cropping of original gel image for clarity, all important bands retainedBack to article page